| First Author | Yoo SW | Year | 2020 |
| Journal | Sci Adv | Volume | 6 |
| Issue | 40 | PubMed ID | 33008902 |
| Mgi Jnum | J:351271 | Mgi Id | MGI:6804358 |
| Doi | 10.1126/sciadv.aba5210 | Citation | Yoo SW, et al. (2020) Inhibition of neutral sphingomyelinase 2 promotes remyelination. Sci Adv 6(40) |
| abstractText | Myelination requires a highly organized synthesis of multiple lipid species that regulate myelin curvature and compaction. For reasons that are not understood, central nervous system remyelinated axons often have thin myelin sheaths with a disorganized structure susceptible to secondary demyelination. We found that expression of the sphingomyelin hydrolase neutral sphingomyelinase 2 (nSMase2) during the differentiation of oligodendrocyte progenitor cells (OPCs) to myelinating oligodendrocytes changes their response to inflammatory cytokines. OPCs do not express nSMase2 and exhibit a protective/regenerative response to tumor necrosis factor-alpha and interleukin-1beta. Oligodendrocytes express nSMase2 and exhibit a stress response to cytokine challenge that includes an overproduction of ceramide, a sphingolipid that forms negative curvatures in membranes. Pharmacological inhibition or genetic deletion of nSMase2 in myelinating oligodendrocytes normalized the ceramide content of remyelinated fibers and increased thickness and compaction. These results suggest that inhibition of nSMase2 could improve the quality of myelin and stabilize structure. |
